Merck, Daiichi pull lung cancer filing after FDA pushback deals another blow to $4B deal1 report from 1 outlet in 1 language · first reported 2026-09-28 10:22 UTC · updated 2026-09-28 10:22 UTC · JSONEconomy & businessMerckBest Denki (Taiwan)United States Food and Drug AdministrationReportsMerck, Daiichi pull lung cancer filing after FDA pushback deals another blow to $4B dealfiercebiotech.com · en · 2026-09-28 10:22 UTC